These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 29329936

  • 21. Continuous levodopa infusions to treat complex dystonia in Parkinson's disease.
    Sage JI, McHale DM, Sonsalla P, Vitagliano D, Heikkila RE.
    Neurology; 1989 Jul; 39(7):888-91. PubMed ID: 2472582
    [Abstract] [Full Text] [Related]

  • 22. Variable PARK2 Mutations Cause Early-Onset Parkinson's Disease in a Small Restricted Population.
    Ben-Shachar S, Afawi Z, Masalha R, Badarny S, Neiman T, Pavzner D, Bar-Shira A, Orr-Urtreger A.
    J Mol Neurosci; 2017 Oct; 63(2):216-222. PubMed ID: 28913705
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Subthalamic local field potentials in Parkinson's disease and isolated dystonia: An evaluation of potential biomarkers.
    Wang DD, de Hemptinne C, Miocinovic S, Qasim SE, Miller AM, Ostrem JL, Galifianakis NB, San Luciano M, Starr PA.
    Neurobiol Dis; 2016 May; 89():213-22. PubMed ID: 26884091
    [Abstract] [Full Text] [Related]

  • 25. Hereditary progressive dystonia with marked diurnal fluctuation. Pathophysiological importance of the age of onset.
    Segawa M, Nomura Y.
    Adv Neurol; 1993 May; 60():568-76. PubMed ID: 8420193
    [No Abstract] [Full Text] [Related]

  • 26. Dopaminergic drug-induced tics in PARK2-positive Parkinson's disease.
    Dafotakis M, Fink GR, Nowak DA.
    Mov Disord; 2008 Mar 15; 23(4):628. PubMed ID: 18181204
    [No Abstract] [Full Text] [Related]

  • 27. Novel human pathological mutations. Gene symbol: PARK2. Disease: Parkinson's disease.
    Cirò Candiano IC, Annesi F, Rocca EF, Carrideo S, Tarantino P, Provenzano G, Civitelli D, De Marco EV, Quattrone A, Annesi G.
    Hum Genet; 2007 Nov 15; 122(3-4):416. PubMed ID: 18350653
    [No Abstract] [Full Text] [Related]

  • 28. Novel human pathological mutations. Gene symbol: PARK2. Disease: Parkinson's disease.
    Tarantino P, Cirò Candiano IC, Annesi F, Rocca FE, Carrideo S, Provenzano G, Civitelli D, De Marco EV, Quattrone A, Annesi G.
    Hum Genet; 2007 Nov 15; 122(3-4):415. PubMed ID: 18350649
    [No Abstract] [Full Text] [Related]

  • 29. Novel human pathological mutations. Gene symbol: PARK2. Disease: Parkinson's disease.
    Rocca FE, Annesi F, Cirò Candiano IC, Carrideo S, Tarantino P, Provenzano G, Civitelli D, De Marco EV, Quattrone A, Annesi G.
    Hum Genet; 2007 Nov 15; 122(3-4):415. PubMed ID: 18350651
    [No Abstract] [Full Text] [Related]

  • 30. Novel human pathological mutations. Gene symbol: PARK2. Disease: Parkinson's disease.
    Annesi F, Rocca EF, Cirò Candiano IC, Carrideo S, Tarantino P, Provenzano G, Civitelli D, De Marco EV, Quattrone A, Annesi G.
    Hum Genet; 2007 Nov 15; 122(3-4):415. PubMed ID: 18350652
    [No Abstract] [Full Text] [Related]

  • 31. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N.
    Rinsho Shinkeigaku; 2004 Nov 15; 44(4-5):241-62. PubMed ID: 15287506
    [Abstract] [Full Text] [Related]

  • 32. Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model.
    de la Fuente-Fernández R, Schulzer M, Mak E, Calne DB, Stoessl AJ.
    Brain; 2004 Apr 15; 127(Pt 4):888-99. PubMed ID: 14960500
    [Abstract] [Full Text] [Related]

  • 33. Dystonia in Parkinson's disease.
    Tolosa E, Compta Y.
    J Neurol; 2006 Dec 15; 253 Suppl 7():VII7-13. PubMed ID: 17131231
    [Abstract] [Full Text] [Related]

  • 34. Low frequency of Parkin, Tyrosine Hydroxylase, and GTP Cyclohydrolase I gene mutations in a Danish population of early-onset Parkinson's Disease.
    Hertz JM, Ostergaard K, Juncker I, Pedersen S, Romstad A, Møller LB, Güttler F, Dupont E.
    Eur J Neurol; 2006 Apr 15; 13(4):385-90. PubMed ID: 16643317
    [Abstract] [Full Text] [Related]

  • 35. Lower limb post-immobilization dystonia in Parkinson's disease.
    Singer C, Papapetropoulos S.
    J Neurol Sci; 2005 Dec 15; 239(1):111-4. PubMed ID: 16182312
    [Abstract] [Full Text] [Related]

  • 36. Genetic and environmental findings in early-onset Parkinson's disease Brazilian patients.
    Aguiar Pde C, Lessa PS, Godeiro C, Barsottini O, Felício AC, Borges V, Silva SM, Saba RA, Ferraz HB, Moreira-Filho CA, Andrade LA.
    Mov Disord; 2008 Jul 15; 23(9):1228-33. PubMed ID: 18464276
    [Abstract] [Full Text] [Related]

  • 37. Pisa syndrome as a motor complication of Parkinson's disease.
    Kim JS, Park JW, Chung SW, Kim YI, Kim HT, Lee KS.
    Parkinsonism Relat Disord; 2007 Mar 15; 13(2):126-8. PubMed ID: 16731022
    [Abstract] [Full Text] [Related]

  • 38. No differential DNA methylation of PARK2 in brain of Parkinson's disease patients and healthy controls.
    De Mena L, Cardo LF, Coto E, Alvarez V, Coto E.
    Mov Disord; 2013 Dec 15; 28(14):2032-3. PubMed ID: 23868535
    [No Abstract] [Full Text] [Related]

  • 39. Young-onset Parkinson's disease: a clinical review.
    Golbe LI.
    Neurology; 1991 Feb 15; 41(2 ( Pt 1)):168-73. PubMed ID: 1992358
    [Abstract] [Full Text] [Related]

  • 40. Patterning of globus pallidus local field potentials differs between Parkinson's disease and dystonia.
    Silberstein P, Kühn AA, Kupsch A, Trottenberg T, Krauss JK, Wöhrle JC, Mazzone P, Insola A, Di Lazzaro V, Oliviero A, Aziz T, Brown P.
    Brain; 2003 Dec 15; 126(Pt 12):2597-608. PubMed ID: 12937079
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.